Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
Keyword(s):
2019 ◽
Vol 131
(7)
◽
pp. 453-460
◽
2020 ◽
Vol 43
(4)
◽
pp. 316-323
2017 ◽
Vol 32
(4)
◽
pp. 536-545
◽
2021 ◽
Vol 3
(3)
◽
pp. 1681-1688
Keyword(s):
Keyword(s):